This inventor holds 1 USPTO granted patent. Top assignee: Giuliani S.p.a.. Active years: 1992.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1992
Title: Virginio Castagnola: A Legacy in Pharmaceutical Innovation
Introduction
Virginio Castagnola was a notable inventor whose contributions to the field of pharmaceuticals have left a lasting impact. Based in Milan, Italy, he is remembered for his innovative approach to gastrointestinal treatments. His work has paved the way for advancements in diagnostic and therapeutic applications.
Latest Patents
Castagnola held a patent for an orally administered pharmaceutical composition designed for gastrointestinal washes. This invention is particularly useful for diagnostic purposes or as a cathartic laxative. The composition includes polyethyleneglycol, anhydrous sodium sulphate, sodium bicarbonate, sodium chloride, and potassium chloride, along with saccharin, acesulfame-K, and a flavoring such as mandarin or fresh fruit flavoring. This patent highlights his commitment to improving patient care through effective and palatable medical solutions.
Career Highlights
Throughout his career, Castagnola was associated with Giuliani S.p.A., a company known for its dedication to pharmaceutical innovation. His work there contributed significantly to the development of effective gastrointestinal treatments. His expertise and dedication to research have made a notable difference in the industry.
Collaborations
Castagnola collaborated with esteemed colleagues such as Enzo Giorgetti and Giuliano Frigerio. Their combined efforts in research and development have further advanced the field of pharmaceuticals, showcasing the importance of teamwork in innovation.
Conclusion
Virginio Castagnola's contributions to pharmaceutical science, particularly in gastrointestinal treatments, have established him as a significant figure in the industry. His legacy continues to inspire future innovations in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile